Raanana, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
Polyrizon Ltd., a biotech company focused on developing intranasal hydrogels, has started preclinical studies for an intranasal formulation of Naloxone, intended to treat opioid overdoses.
Though many Illinois libraries already have supplies of medications that can reverse opioid overdoses, a new state law will ...
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
There was no difference in survival between recipients of 4-mg or 8-mg intranasal naloxone (Narcan) administered by law enforcement, according to data from New York state. A review of 354 naloxone ...
A higher dose version of naloxone, the nasal spray used to reverse opioid-induced overdoses, did not lead to more saved lives, according to a new study published earlier this month. The findings, ...
Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) ...
Ra’anana, Israel, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today ...
RA’ANANA, ISRAEL - Polyrizon Ltd. (NASDAQ:PLRZ) announced Thursday that its intranasal naloxone hydrogel formulation demonstrated favorable permeation kinetics in preclinical testing, complementing ...
The University of Michigan Health-Sparrow has installed Narcan vending machines at its Carson and Clinton community hospitals ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback